The Lancet Infectious Diseases

Title Publication Date Language Citations
The global burden of group A streptococcal diseases2005/11/01English31
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases2013/09/01English29
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern2008/03/01English28
Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study2021/07/01English28
Human brucellosis2007/12/01English28
Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis2019/01/01English27
Viral dynamics in mild and severe cases of COVID-192020/06/01English27
Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial2019/01/01English26
Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study2020/06/01English26
Ageing and infection2002/11/01English26
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics2020/09/01English26
Convalescent plasma as a potential therapy for COVID-192020/04/01English26
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study2010/09/01English26
Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study2012/09/01English25
Effect of washing hands with soap on diarrhoea risk in the community: a systematic review2003/05/01English24
Klebsiella pneumoniae liver abscess: a new invasive syndrome2012/11/01English24
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial2021/06/01English22
Clinical and virological data of the first cases of COVID-19 in Europe: a case series2020/06/01English22
Scientific and ethical basis for social-distancing interventions against COVID-192020/06/01English22
What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-22021/02/01English22
Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study2013/09/01English22
Hand, foot, and mouth disease in China, 2008–12: an epidemiological study2014/04/01English22
Virology, epidemiology, pathogenesis, and control of enterovirus 712010/11/01English21
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance2021/06/01English21
Streptococcus pneumoniae colonisation: the key to pneumococcal disease2004/03/01English21
Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study2020/05/01English21
COVID-19 and medical education2020/07/01English21
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections2006/09/01English21
COVID-19 and multisystem inflammatory syndrome in children and adolescents2020/11/01English20
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis2007/07/01English20